Hoffmann A, Oborn B, Moteabbed M, Yan S, Bortfeld T, Knopf A, Fuchs H, Georg D, Seco J, Spadea MF, Jäkel O, Kurz C, Parodi K.
MR-guided proton therapy: a review and a preview.
Radiat Oncol. 2020;15(1):129.

Causer TJ, Schellhammer SM, Gantz S, Lühr A, Hoffmann AL, Metcalfe PE, Rosenfeld AB, Guatelli S, Petasecca M, Oborn BM.
First application of a high-resolution silicon detector for proton beam Bragg peak detection in a 0.95 T magnetic field.
Med Phys. 2020;47(1):181-189.


Peerlings J, Paulis L, Mitea C, Bakers F, Berbée M, Wierts R, Vöö S, Wildberger J, Hoffmann A, Lambin P, Mottaghy F.
Performing clinical 18F-FDG-PET/MRI of the mediastinum optimising a dedicated, patient-friendly protocol.
Nucl Med Commun. 2019;40(8):815-826.

Schneider S, Aust DE, Brückner S, Welsch T, Hampe J, Troost EGC, Hoffmann AL.
Detectability and structural stability of a liquid fiducial marker in fresh ex vivo pancreas tumour resection specimens on CT and 3T MRI.
Strahlenther Onkol. 2019;195(8):756-763.

Dolde K, Schneider S, Stefanowicz S, Alimusaj M, Flügel B, Saito N, Troost EGC, Pfaffenberger A, Hoffmann AL.
Comparison of pancreatic respiratory motion management with three abdominal corsets for particle radiation therapy: Case study.
J Appl Clin Med Phys. 2019;20(6):111-119.

Lühr A, Burigo LN, Gantz S, Schellhammer SM, Hoffmann AL.
Proton beam electron return effect: Monte Carlo simulations and experimental verification.
Phys Med Biol. 2019 ;64(3):035012.

Schneider S, Dolde K, Engler J, Hoffmann A, Pfaffenberger A.
Commissioning of a 4D MRI phantom for use in MR-guided radiotherapy.
Med Phys. 2019;46(1):25-33.


Alessandra Bolsi, Marta Peroni, Dante Amelio, Alexandru Dasu, Markus Stock, Iuliana Toma-Dasu, Petra Witt Nyström, und Aswin Hoffmann. „Practice Patterns of Image Guided Particle Therapy in Europe: A 2016 Survey of the European Particle Therapy Network (EPTN)“. Radiotherapy and Oncology, 128, 1 (2018): 4–8.

Daniëlle B. P. Eekers, Esther N. Pijnappel, Olaf E. M. G. Schijns, Albert Colon, Ann Hoeben, Jaap D. Zindler, Alida A. Postma, Aswin L. Hoffmann, Philippe Lambin, und Esther G. C. Troost. „Evidence on the Efficacy of Primary Radiosurgery or Stereotactic Radiotherapy for Drug-Resistant Non-Neoplastic Focal Epilepsy in Adults: A Systematic Review“. Seizure 55 ( 2018): 83–92.

Sonja M. Schellhammer, Sebastian Gantz, Armin Lühr, Bradley M. Oborn, Michael Bussmann, und Aswin L. Hoffmann. „Technical Note: Experimental Verification of Magnetic Field-Induced Beam Deflection and Bragg Peak Displacement for MR-Integrated Proton Therapy“. Medical Physics 45, 7 (2018): 3429–34.

Sergej Schneider, Rasmus Irming Jølck, Esther Gera Cornelia Troost, und Aswin Louis Hoffmann. „Quantification of MRI Visibility and Artifacts at 3T of Liquid Fiducial Marker in a Pancreas Tissue-Mimicking Phantom“. Medical Physics 45, 1 (2018): 37–47.

Ben G. L. Vanneste, Y. van Wijk, L. C. Lutgens, E. J. Van Limbergen, E. N. van Lin, K. van de Beek, P. Lambin, und A. L. Hoffmann. „Dynamics of Rectal Balloon Implant Shrinkage in Prostate VMAT : Influence on Anorectal Dose and Late Rectal Complication Risk“. Strahlentherapie Und Onkologie: Organ Der Deutschen Röntgengesellschaft, 194, 1 (2018): 31–40.

Jaap D. Zindler, Jaqueline Schiffelers, Philippe Lambin, und Aswin L. Hoffmann. "Improved Effectiveness of Stereotactic Radiosurgery in Large Brain Metastases by Individualized Isotoxic Dose Prescription: An in Silico Study". Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft, 194, 6 (2018): 560-69.



Wijsman, R., Dankers, F., Troost, E.G.C., Hoffmann, A., van der Heijden, E.H.F.M., de Geus-Oei, L.-F., Bussink, J. Inclusion of incidental radiation dose to the cardiac atria and ventricles does not improve the prediction of radiation pneumonitis in advanced stage non-small cell lung cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (IF 4.258) [in press]

Dankers, F., Wijsman, R., Troost, E.G.C., Monshouwer, R., Bussink, J., Hoffmann, A.LEsophageal wall dose-surface maps do not improve the predictive performance of a multivariable NTCP model for acute esophageal toxicity in advanced stage NSCLC patients treated with intensity-modulated (chemo-)radiotherapy. Phys Med Biol 62(9): 3668–81; 2017 (IF 2.811)

Schellhammer, S., Hoffmann, A.L. A novel method for fast and accurate estimation and compensation of magnetic beam deflection in MR-integrated proton therapy. Phys Med Biol 62(4): 1548–64; 2017 (IF 2.811)

Wijsman, R., Dankers, F., Troost, E.G.C., Hoffmann, A., van der Heijden, E.H.F.M., de Geus-Oei, L.-F., Bussink, J. Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT. Radiother Oncol 122(2): 295-9; 2017 (IF 4.817)


Vanneste*, B., Hoffmann*, A.L., van Lin, E., Van de Voorde, L., Schubert, C., Pinkawa, M. Lambin, P. Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection. Radiother Oncol. 121(1): 118−32; 2016 (IF 4.363)

Zindler, J.D., Hahn, S., Thomas, C.R. Jr., Hoffmann, A.L., Troost, E.G.C., Lambin, P. Increasing the therapeutic ratio of stereotactic radiotherapy by individualized isotoxic dose prescription based on normal tissue tolerance levels. J Natl Cancer Inst 108(2): djv305; 2016. (IF 12.583)

Peerlings, J., Troost, E.G.C., Nelemans, P., Cobben, D.C.P., de Boer, J.C.J., Hoffmann*, A.L., Beets-Tan*, R., The diagnostic value of MRI in determining the lymph node status of patients with non-small cell lung cancer: a meta-analysis. Radiology 281(1): 86–98; 2016. (IF 6.867)

Pilz, K., Hoffmann, A., Baumann, M. Troost, E.G.C. Vertebral fractures – An underestimated side-effect in patients treated with radio(chemo)therapy. Radiother Oncol 2016 118(3): 421–3; 2016. (IF 4.363)

Compter, J. Peerlings, J., Eekers D.B., Postma, A.A., Ivanov, D., Wiggins, C., Kubben, P., Küsters B, Wesseling, P., Ackermans, P.C.M., Schijns, O.E.M.G., Lambin, P., Hoffmann, A.L. Technical feasibility of integrating 7T anatomical MRI in image-guided radiotherapy of glioblastoma: a preparatory study. Magn Reson Mater Phy 29: 591-603 2016. (IF 2.869)

Tops, S., Wetzels, J., Dooper, I., Langenhuijsen, H., d’Ancona, F., van der Vliet, D., Dekker, H., Hoffmann, A., Kloke, H. Kidney weight in living and postmortal kidney donation. Transplantation 100(1): e1–2; 2016. (IF 3.828)


Wijsman, R., Dankers, F., Troost, E.G.C., Hoffmann, A., van der Heijden, E.H.F.M., de Geus-Oei, L.-F., Bussink, J. Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients with intensity-modulated (chemo-)radiotherapy. Radiother Oncol 117(1): 49–54; 2015. (IF 4.817)

Cobben, D.C.P., de Boer, H.C.J., Tijssen, R.H., Rutten, E.G.G.M., van Vulpen, M., Peerlings, J., Troost, E.G.C., Hoffmann, A.L., van Lier, A.L. Emerging role of MRI for radiation treatment planning in lung cancer. Technol Cancer Res Treat. 15(6) NP47–60; 2016 (IF 1.730)

Steenhuijsen, J., de Leeuw, A., Harbers, M., Hoffmann, A., Reymen, R., Unipan, M., Rijnders, A. Code of practice for quality assurance of applicators and transfer tubes for Ir-192 afterloaders. Netherlands Commission on Radiation Dosimetry.

Balvert, M., van Hoof, S.J., Granton, P.V., Trani, D. den Hertog, D., Hoffmann, A.L., Verhaegen, F. A framework for inverse planning of beam-on times for 3D small animal radiotherapy using interactive multi-objective optimisation. Phys Med Biol 60(14): 5681–98; 2015. (IF 2.761)

Balvert, M., Gorissen B.L., den Hertog, D. & Hoffmann, A.L. Dwell time modulation restrictions do not necessarily improve treatment plan quality for prostate HDR brachytherapy. Phys Med Biol 60(2) 537–48; 2015. (IF 2.761)